The Asian Scientist 100
Tan Eng King
Institution
National Neuroscience Institute
Country
Singapore
Field
Life Sciences
Tan Eng King received the 2018 President’s Science Award for identifying clinical biomarkers, developing novel models and transforming patient care in Parkinson’s Disease. (Photo: National Neuroscience Institute)
Related articles
AI Enables Personalized Treatment For Myeloma
A multidisciplinary team of researchers has developed an artificial intelligence platform that could enable doctors to prescribe personalized treatments for myeloma patients.
Making Wood Out Of Synthetic Resin
Researchers in China have developed a family of bioinspired artificial wood from phenolic and melamine resin.
Asia’s Rising Scientists: Ho Weang Kee
In a bid to reduce breast cancer mortality, Associate Professor Ho Weang Kee is developing a tool to catch the disease early.
Antibiotic Resistance Genes Traveling On The Wind
The air in Beijing carries the greatest diversity of antibiotic resistance genes, while San Francisco has the highest levels of airborne antibiotic resistance genes, say researchers.
AI For Everyone
Rather than dominate the TOP500 rankings, the ABCI supercomputer was designed to bring computing capacity for AI applications to the masses, says AIST’s Satoshi Sekiguchi.
5 Ways Supercomputers Make Cities Smart
Supercomputers are helping urban planners run simulations, make predictions and build models, bringing the dream of a smart city closer to reality.
Raising A City’s IQ
Smart cities represent a tremendous opportunity to improve the lives of millions, but many technical challenges stand in the way. Here’s how high performance computing is being used to address several of the most difficult ones.
Turning The Hourglass Sideways
Science is challenging the notion that aging is an inescapable fact of life. Here are six strategies that have been shown to prolong life in model organisms, and, in some cases, even humans.
Engineered Antibody Neutralizes All Four Dengue Serotypes
Researchers have designed an antibody that targets all four serotypes of dengue, sparking hopes for the first viable dengue therapeutic.









